"Driving the news: Under Trump's new plan, which was first reported by the Washington Post, the president would reclassify marijuana, which is banned under federal law. Not only would reclassification ease regulations, but it would make it easier to conduct medical research and possibly create tax breaks for cannabis companies. Cannabis stocks surged in wake of Trump's potential shift. The change comes after the World Health Organization recently added a formal name to a deadly cannabis-related condition,"
"The federal Controlled Substances Act classifies marijuana as a "Schedule I controlled substance," meaning the drug has high abuse potential and it cannot be accepted for medical use. This is the same category as LSD, ecstasy and peyote. The law specifically restricts the manufacture, distribution, dispensing, and possession of Schedule I substances - except for federal research purposes. State of play: Under former President Biden, the Department of Health and Human Services recommended"
Marijuana is federally classified as a Schedule I controlled substance, placing it alongside LSD, ecstasy and peyote and restricting manufacture, distribution and possession except for federal research. The Trump administration is reportedly considering reclassifying marijuana to Schedule III, which would permit medical use and align it with drugs such as ketamine, anabolic steroids and testosterone. Reclassification would ease regulations, facilitate medical research, and could enable tax breaks for cannabis companies. The World Health Organization added a formal name to a deadly cannabis-related condition that was adopted by the CDC. Federal law supersedes state law, but many agencies follow state marijuana regulations.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]